August 24, 2021 Comments Off on New patent for Boehringer Ingelheim drug GLYXAMBI Posted in: Patent Added Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Boehringer Ingelheim drug GLYXAMBI appeared…
August 24, 2021 Comments Off on New patent for Jazz Pharms drug DEFITELIO Posted in: Patent Added Annual Drug Patent Expirations for DEFITELIO Defitelio is a drug marketed by Jazz Pharms Inc and is included in one NDA. It is available from one supplier. The generic ingredient…
The post New patent for Jazz Pharms drug DEFITELIO appeared first on Dru…
